👇English and Malay language

Covid-19 vaccination: MOH to provide financial assistance for people affected by serious side effects

• A payment of up to S$10,000 will be made to those suffering serious side effects after getting a Covid-19 vaccine
• This has to be judged by doctors to have been linked to the vaccine
• A payment of S$225,000 will be made if a person dies or suffers severe permanent disability
• More than 113,000 people have received their first dose of the Pfizer-BioNTech Covid-19 vaccine
• There have been 432 “adverse event reports” from these, which were resolved within a few days 

SINGAPORE — The Ministry of Health on Thursday (Jan 28) announced it will provide financial aid for those who suffer serious side effects from getting their Covid-19 vaccines in Singapore. However, it expects “few” people will need the programme, which is meant to “give a greater peace of mind for those taking the vaccination”.

In a press statement, MOH added that more than 113,000 people in Singapore have received their first dose of the Pfizer-BioNTech Covid-19 vaccine, while more than 50 of them have completed their full vaccination regime after receiving their second dose.

Of those who have been vaccinated, there have been 432 “adverse event reports” from healthcare professionals, MOH said.

“Most of these reports were for regular symptoms such as injection site pain and swelling, fever, headache, fatigue, body aches, giddiness, nausea and allergic reactions such as itch, rash, swelling of eyes or lips or both.

“These symptoms are reactions generally associated with all vaccinations and they generally resolved on their own within a few days.”

Three people suffered anaphylaxis, which is a severe allergic reaction known to be experienced by a very small proportion of the population. All had recovered after a day in hospital and had been discharged.

S’pore builds stockpile of locally-made filters for reusable masks, for use only if pandemic worsens

HOW THE FINANCIAL SCHEME WORKS

The financial assistance scheme is called the vaccine injury financial assistance programme for Covid-19 vaccination (Vifap). It will provide two tiers of support to those who may be adversely affected by their inoculation.

The first is a one-time payout of up to S$10,000 that will be given to those who were hospitalised and required care in the high dependency or intensive care unit, but later recover from the side effects caused by the vaccine.

The second is a payout of S$225,000 that will be provided when a person dies or suffers permanent severe disability as a result of the vaccination.

MOH stressed that those who have experienced serious side effects after their Covid-19 vaccinations can continue to receive support through the applicable healthcare schemes, such as the Central Provident Fund’s MediShield Life as well as subsidies at Singapore’s public healthcare institutions.

To qualify for the financial support, the person must be a Singaporean, permanent resident or long-term pass holder who received their vaccination here.

Vaccination exercise for seniors kicks off at Ang Mo Kio, Tanjong Pagar; almost 100,000 people in S’pore have had jab so far

The person must have “experienced a serious side effect that is potentially life-threatening or fatal, and has required inpatient hospitalisation or has caused persistent incapacity or disability”, MOH said.

These serious side effects must then be assessed by a doctor to be linked to the Covid-19 vaccination.

MOH said that it has since also appointed an independent clinical panel comprising experts in the relevant fields such as neurology, immunology and infectious diseases, to assess and adjudicate Vifap applications. This is because the “severity of (the) serious side effects can be broad, and assessment by the treating doctors may vary”.

MAXIMISING PROTECTION AGAINST COVID-19

The ministry stressed that vaccination is critical to protect “us and our loved ones”, especially those in the community who cannot be vaccinated due to medical reasons.

This collective protection will become more effective as more people are vaccinated and is a “key enabler allowing us to return to normalcy”.

Covid-19: 34 new imported cases; 2 test ‘preliminarily positive’ for more contagious British strain

“We strongly encourage Singaporeans and long-term residents to come forward for vaccination when their turn comes, so that as a society, we can keep each other safe from the disease.

“Even as we progressively vaccinate our population, we must keep in mind that vaccination is not a silver bullet. We must continue to adhere to the safe management measures to help us mitigate the spread and keep community transmission low,” it said.

It added that the three reported cases of anaphylaxis involving the rapid onset of severe allergic reactions were “quickly resolved by healthcare professionals”.

“The individuals, in their 20s and 30s, developed multiple symptoms such as rash, breathlessness, lip swelling, throat tightness and giddiness.” 

All three individuals had a history of allergies, including allergic rhinitis and food allergy such as to shellfish, but none had a history of anaphylaxis that would have precluded them from receiving the vaccine.

MOH added that anaphylaxis can be controlled when detected and treated in a timely manner. As all vaccinated persons in Singapore are closely monitored, the symptoms in these three individuals were promptly detected and treated.

Exercise restraint during CNY activities this year to avoid ‘real risk’ of second circuit breaker: PM Lee

“All have recovered from the episode and were discharged from the hospital after a day’s observation or treatment.”

The incidence rate of anaphylaxis here is now about 2.7 for every 100,000 doses administered.

The incidence rates reported abroad is around one to two per 100,000 doses administered, after millions of vaccine doses have been administered. Variations in the incidence rate are to be expected initially as the numbers vaccinated in Singapore to-date are relatively small.

Associate Professor Kenneth Mak, Director of Medical Services at MOH, said that anaphylaxis is a known but rare side effect of the Pfizer-BioNTech Covid-19 vaccine.

“As with all vaccines, there will always be a small proportion of susceptible persons who experience severe allergic reactions upon vaccination,” he said.

“We have put in place precautionary measures such as pre-vaccination screening and post-vaccination observation, to ensure that our vaccination programme can be carried out safely,” he added.

President Halimah Yacob receives first dose of Pfizer-BioNTech Covid-19 vaccine

“Vaccination remains safe for those who are eligible, and I encourage all Singaporeans and long-term residents to be vaccinated when your turn comes.”

SINGAPORE — The Ministry of Health on Thursday (Jan 28) announced it will provide financial aid for those who suffer serious side effects from getting their Covid-19 vaccines in Singapore. However, it expects “few” people will need the programme, which is meant to “give a greater peace of mind for those taking the vaccination”.

— Read on www.todayonline.com/singapore/covid-19-vaccination-moh-provide-financial-assistance-people-affected-serious-side-effects

Vaksinasi Covid-19: KKM untuk memberikan bantuan kewangan untuk orang yang terkena kesan sampingan yang serius

Seorang warga emas mendapatkan vaksin Pfizer-BioNTech Covid-19 di Tanjong Pagar Community Club pada 27 Jan 2021.

Nuria Ling / HARI INI

Bayaran sehingga S $ 10,000 akan dibuat kepada mereka yang mengalami kesan sampingan yang serius setelah mendapat vaksin Covid-19

Ini harus dinilai oleh doktor yang berkaitan dengan vaksin

Bayaran sebanyak S $ 225,000 akan dibuat sekiranya seseorang mati atau mengalami kecacatan kekal yang teruk

Lebih daripada 113,000 orang telah menerima dos pertama vaksin Pfizer-BioNTech Covid-19 mereka

Ada 432 “laporan kejadian buruk” dari ini, yang diselesaikan dalam beberapa hari

SINGAPURA – Kementerian Kesihatan pada hari Khamis (28 Jan) mengumumkan akan memberikan bantuan kewangan bagi mereka yang mengalami kesan sampingan serius dari mendapatkan vaksin Covid-19 mereka di Singapura. Namun, pihaknya mengharapkan “sedikit” orang yang memerlukan program ini, yang dimaksudkan untuk “memberikan ketenangan pikiran bagi mereka yang mengambil vaksinasi”.

Dalam satu kenyataan media, KKM menambah bahawa lebih daripada 113,000 orang di Singapura telah menerima dos pertama vaksin Pfizer-BioNTech Covid-19 mereka, sementara lebih dari 50 daripadanya telah menyelesaikan rejim vaksinasi penuh mereka setelah menerima dos kedua mereka.

Dari mereka yang telah divaksinasi, ada 432 “laporan kejadian buruk” dari profesional kesihatan, kata KKM.

“Sebilangan besar laporan ini adalah untuk gejala biasa seperti sakit dan pembengkakan di tempat suntikan, demam, sakit kepala, keletihan, sakit badan, pusing, mual dan reaksi alergi seperti gatal, ruam, bengkak mata atau bibir atau kedua-duanya.

“Gejala-gejala ini adalah reaksi yang biasanya dikaitkan dengan semua vaksinasi dan mereka biasanya dapat diselesaikan sendiri dalam beberapa hari.”

Tiga orang menderita anafilaksis, yang merupakan reaksi alergi yang teruk yang diketahui dialami oleh sebilangan kecil populasi. Semua telah pulih setelah seharian di hospital dan diberhentikan.

S’pore membina stok penapis buatan tempatan untuk topeng yang boleh digunakan semula, untuk digunakan hanya jika pandemi bertambah buruk

BAGAIMANA SKIM KEWANGAN BERFUNGSI

Skim bantuan kewangan dipanggil program bantuan kewangan kecederaan vaksin untuk vaksinasi Covid-19 (Vifap). Ini akan memberikan dua tahap sokongan kepada mereka yang mungkin terjejas oleh inokulasi mereka.

Yang pertama adalah pembayaran sekali sehingga S $ 10,000 yang akan diberikan kepada mereka yang dirawat di hospital dan memerlukan rawatan di unit bergantung tinggi atau rawatan intensif, tetapi kemudian pulih dari kesan sampingan yang disebabkan oleh vaksin.

Yang kedua adalah pembayaran sebanyak S $ 225,000 yang akan diberikan apabila seseorang mati atau mengalami kecacatan teruk yang berterusan akibat vaksinasi.

KKM menekankan bahawa mereka yang mengalami kesan sampingan yang serius setelah vaksinasi Covid-19 mereka dapat terus mendapat sokongan melalui skim penjagaan kesihatan yang berlaku, seperti MediShield Life Central Provident Fund dan juga subsidi di institusi kesihatan awam Singapura.

Untuk memenuhi syarat untuk mendapatkan sokongan kewangan, orang tersebut mestilah orang Singapura, pemastautin tetap atau pemegang pas jangka panjang yang menerima vaksinasi mereka di sini.

Latihan vaksinasi untuk warga emas bermula di Ang Mo Kio, Tanjong Pagar; hampir 100,000 orang di S’pore telah mengalami jab setakat ini

Orang itu mesti “mengalami kesan sampingan yang serius yang berpotensi mengancam nyawa atau membawa maut, dan memerlukan rawatan di hospital atau menyebabkan ketidakupayaan atau kecacatan yang berterusan”, kata KKM.

Kesan sampingan yang serius ini mesti dinilai oleh doktor untuk dikaitkan dengan vaksinasi Covid-19.

KKM mengatakan bahawa sejak itu juga telah melantik panel klinikal bebas yang terdiri daripada pakar dalam bidang yang berkaitan seperti neurologi, imunologi dan penyakit berjangkit, untuk menilai dan memutuskan aplikasi Vifap. Ini kerana “keparahan (kesan) serius yang serius boleh menjadi luas, dan penilaian oleh doktor yang merawat mungkin berbeza-beza”.

Maksimumkan Perlindungan Terhadap COVID-19

Kementerian menekankan bahawa vaksinasi sangat penting untuk melindungi “kita dan orang yang kita sayangi”, terutama mereka yang tidak dapat diberi vaksin kerana alasan perubatan.

Perlindungan kolektif ini akan menjadi lebih berkesan kerana lebih banyak orang diberi vaksin dan merupakan “pemboleh utama yang membolehkan kita kembali normal”.

Covid-19: 34 kes import baru; 2 ujian ‘positif awal’ untuk tekanan Inggeris yang lebih menular

“Kami sangat mendorong warga Singapura dan penduduk jangka panjang untuk tampil untuk vaksinasi ketika tiba gilirannya, sehingga sebagai masyarakat, kita dapat saling menjaga keselamatan dari penyakit ini.

“Walaupun kita memvaksinasi penduduk kita secara progresif, kita harus ingat bahawa vaksinasi bukanlah peluru perak. Kita mesti terus mematuhi langkah-langkah pengurusan yang selamat untuk membantu kita mengurangkan penyebaran dan memastikan penularan komuniti tetap rendah, ”katanya.

Ia menambah bahawa tiga kes anafilaksis yang dilaporkan yang melibatkan permulaan reaksi alergi yang teruk “diselesaikan dengan cepat oleh profesional penjagaan kesihatan”.

“Individu itu, berusia 20-an dan 30-an, mengalami pelbagai gejala seperti ruam, sesak nafas, bengkak bibir, sesak tekak dan pening.”

Ketiga-tiga individu mempunyai sejarah alergi, termasuk rinitis alergi dan alergi makanan seperti kerang, tetapi tidak ada yang mempunyai sejarah anafilaksis yang akan menghalangi mereka menerima vaksin.

KKM menambah bahawa anafilaksis dapat dikawal apabila dikesan dan dirawat tepat pada waktunya. Oleh kerana semua orang yang diberi vaksin di Singapura dipantau dengan teliti, gejala pada ketiga-tiga individu ini segera dikesan dan dirawat.

Berhati-hati semasa aktiviti CNY tahun ini untuk mengelakkan ‘risiko sebenar’ pemutus litar kedua: PM Lee

“Semua telah pulih dari episod dan dikeluarkan dari hospital setelah pemerhatian atau rawatan sehari.”

Kadar kejadian anafilaksis di sini kini sekitar 2.7 untuk setiap 100,000 dos yang diberikan.

Kadar kejadian yang dilaporkan di luar negara adalah sekitar satu hingga dua setiap 100,000 dos yang diberikan, setelah berjuta-juta dos vaksin diberikan. Variasi dalam kadar kejadian dijangka pada awalnya kerana jumlah yang divaksin di Singapura hingga kini agak kecil.

Profesor Madya Kenneth Mak, Pengarah Perkhidmatan Perubatan di KKM, mengatakan bahawa anafilaksis adalah kesan sampingan yang diketahui tetapi jarang berlaku dari vaksin Pfizer-BioNTech Covid-19.

“Seperti semua vaksin, akan selalu ada sebilangan kecil orang yang rentan yang mengalami reaksi alergi yang teruk semasa vaksinasi,” katanya.

“Kami telah menerapkan langkah pencegahan seperti pemeriksaan pra-vaksinasi dan pemerhatian pasca vaksinasi, untuk memastikan program vaksinasi kami dapat dijalankan dengan aman,” tambahnya.

Presiden Halimah Yacob menerima dos pertama vaksin Pfizer-BioNTech Covid-19

“Vaksinasi tetap selamat bagi mereka yang layak, dan saya mendorong semua warga Singapura dan penduduk jangka panjang untuk diberi vaksin apabila tiba giliran anda.”